EXTON, Pa.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials science and regenerative medicine, today announced the Company will be participating at the Surfaces in Biomaterials Foundation’s 24th Annual BioInterface Conference 2014, which will be held October 6-8 in Redwood City, California.
- John Zupancich, R&D Manager for Biomedical Polyurethanes, is conducting a workshop on partnering to speed medical innovation, a materials perspective.
- Nik de Bont, Coating Specialist for Application Development and Technical Service, is presenting research on how DSM ComfortCoat® coating (with low particulate characteristics) improves ease of movement of angioplasty devices.
- James Parakka, R&D Manager for Ophthalmic Biomaterials, is co-chairing a session on recent developments in ophthalmology.
- Aylvin Dias, Principal Scientist, is presenting research on amino acid-based biodegradable polyesteramides for drug delivery.
DSM’s presence at the Conference aligns with the Company’s ongoing drive for innovation, tapping into the medical device industry to help develop breakthrough technologies that benefit patient outcomes worldwide.
For more information on the conference please visit the BioInterface Conference 2014 website.
DSM – Bright Science. Brighter Living.™
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 24,500 employees deliver annual net sales of around €10 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.
This press release may contain forward-looking statements with respect to DSM’s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
ComfortCoat® is a registered trademark of DSM